Oxygen Saturation Monitoring in Bronchiolitis

Overview

The investigators will conduct a study around the best way to monitor infants hospitalized with bronchiolitis, the most common lung infection and a leading reason for hospitalization in infants. Infants with bronchiolitis have breathing difficulties and are provided supplemental oxygen if their oxygen levels are low. However, there is uncertainty regarding how to best monitor oxygen levels. A probe placed on the hand or foot can be used to monitor oxygen levels all the time (continuous oxygen monitoring) or just every 4-6 hours (intermittent oxygen monitoring). Research has suggested that placing infants with bronchiolitis on continuous monitoring results in unnecessary use of oxygen and infants staying longer in hospital. However, due to the lack of high quality research, its unclear which strategy is best and practice varies. The objective of this study is to conduct high quality research across hospitals to determine whether intermittent compared to continuous oxygen monitoring will reduce the length of hospital stay in infants hospitalized with bronchiolitis. The investigators will also compare safety and cost. The results of this study will inform bronchiolitis practice standards and the best use of health care resources.

Full Title of Study: “Intermittent vs. Continuous Oxygen Saturation Monitoring in Infants Hospitalized for Bronchiolitis: A Randomized Controlled Trial”

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: Randomized
    • Intervention Model: Parallel Assignment
    • Primary Purpose: Supportive Care
    • Masking: Single (Investigator)
  • Study Primary Completion Date: May 2019

Detailed Description

BACKGROUND This research protocol focuses on bronchiolitis, a leading cause of infant hospitalization and cumulative expense for the health care system. Supportive management, such as oxygen supplementation and monitoring, is the major focus of care, as active medical treatment is not effective. Oxygen saturation monitoring may be performed on an intermittent (e.g. every 4-6hrs) or continuous basis for stable infants hospitalized with bronchiolitis. Observational studies find that the use of continuous monitoring is associated with overuse of supplemental oxygen and longer hospital stay. Based on this low quality evidence, practice guidelines state that clinicians may choose not to use continuous monitoring and practice variation exists due to a lack of RCTs. SPECIFIC AIMS Primary: To determine if intermittent vs continuous oxygen saturation monitoring will reduce length of hospital stay in infants with bronchiolitis. Secondary: To determine differences in other outcomes – effectiveness, safety, acceptability, and cost. METHODOLOGY Design: multi-centre, pragmatic, parallel group, 1:1, two arm superiority RCT. Population: Previously healthy infants (4 weeks-2 years) hospitalized with bronchiolitis who are clinically stable, will be recruited from children's and community hospitals in Ontario, Canada. Interventions: Randomization to intermittent (every 4hrs) or continuous oxygen saturation monitoring. In keeping with local and national clinical practice guidelines, an acceptable oxygen saturation target of ≥ 90% will be used for both groups.

Interventions

  • Other: Intermittent oxygen monitoring
    • Oxygen saturation and vital signs will be measured intermittently at a frequency of every 4 hours by the bedside nurse through the child’s hospital stay until discharge. Vital signs will be completed every 4 hours.
  • Other: Continuous oxygen monitoring
    • Oxygen saturation will be measured continuously through the child’s hospital stay until discharge. Vital signs will be completed every 4 hours.

Arms, Groups and Cohorts

  • Active Comparator: Continuous oxygen monitoring
    • Oxygen saturation will be measured continuously through the child’s hospital stay until discharge.
  • Experimental: Intermittent oxygen monitoring
    • Oxygen saturation will be measured intermittently, every 4 hours, through the child’s hospital stay until discharge.

Clinical Trial Outcome Measures

Primary Measures

  • Length of hospital stay from randomization on the inpatient unit to discharge from hospital
    • Time Frame: 1 month

Secondary Measures

  • Duration of oxygen supplementation from randomization to discontinuation of supplementation
    • Time Frame: 1 month
  • Number of medical interventions performed from time of randomization to hospital discharge
    • Time Frame: 1 month
  • Time from randomization to meeting hospital discharge criteria
    • Time Frame: 1 month
  • Length of hospital stay from inpatient unit admission to hospital discharge
    • Time Frame: 1 month
  • Parent anxiety
    • Time Frame: 1 month
    • Parents will rate their level of anxiety at the current time (state anxiety) and generally (trait anxiety) from the adult State Trait Anxiety Inventory questionnaire during the hospital stay.
  • Number of parent work days missed from randomization to 15 days after discharge
    • Time Frame: 15 days after discharge
  • Nursing satisfaction
    • Time Frame: 1 month
    • The attending nurse will be asked to complete a 10 mm visual analogue scale (VAS) to measure their satisfaction with the quality of monitoring.
  • PICU admission after randomization
    • Time Frame: 1 month
  • PICU consultation after admission
    • Time Frame: 1 month
  • Unscheduled return to care within 15 days of discharge
    • Time Frame: 15 days after discharge
  • Mortality
    • Time Frame: 15 days after discharge.
  • Cost-Effectiveness
    • Time Frame: 15 days after discharge.
    • Cost-effectiveness will be measured by the incremental cost-effectiveness ratio (ICER), a ratio defined by the incremental difference in costs between treatment arms and the incremental difference in length of stay.

Participating in This Clinical Trial

Children admitted to the general pediatric inpatient unit (GPIU) with bronchiolitis will be eligible if their clinical status is stable and not at high risk of deterioration Inclusion Criteria:

  • Clinical diagnosis of bronchiolitis as determined by the attending physician. – First episode of acute bronchiolitis. – Age: 4 weeks to 24 months. – Clinical status stable for 6 hours – Parent consent Exclusion Criteria:

  • Known risk factors for clinical deterioration including chronic medical condition; premature birth (<35weeks), history of apnea, weight < 4kg, receiving morphine – Patient on heated high flow oxygen at enrolment – ICU admission on current admission – No telephone available

Gender Eligibility: All

Minimum Age: 4 Weeks

Maximum Age: 24 Months

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • The Hospital for Sick Children
  • Collaborator
    • Canadian Institutes of Health Research (CIHR)
  • Provider of Information About this Clinical Study
    • Principal Investigator: Sanjay Mahant, Staff Physician – The Hospital for Sick Children
  • Overall Official(s)
    • Sanjay Mahant, Principal Investigator, The Hospital for Sick Children

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.